0001104659-24-043246.txt : 20240403 0001104659-24-043246.hdr.sgml : 20240403 20240403200013 ACCESSION NUMBER: 0001104659-24-043246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwendenman Andrew CENTRAL INDEX KEY: 0001977879 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 24821067 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 500 UNICORN PARK DRIVE CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2410652-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-04-01 0 0001737953 Replimune Group, Inc. REPL 0001977879 Schwendenman Andrew C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK DRIVE, SUITE 303 WOBURN MA 01801 0 1 0 0 Chief Accounting Officer 0 Common Stock 2024-04-01 4 A 0 17775 0 A 40536 D Employee Stock Option (right to buy) 7.73 2024-04-01 4 A 0 53325 0 A 2034-04-01 Common Stock 53325 53325 D Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2025 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2028, subject to the Reporting Person's continuous service to the Issuer. 25% of the shares underlying this stock option vest on April 1, 2025, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. /s/ Shawn Glidden, attorney-in-fact 2024-04-03